331 related articles for article (PubMed ID: 30802916)
1. Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.
Marini I; Bakchoul T
Hamostaseologie; 2019 Aug; 39(3):227-237. PubMed ID: 30802916
[TBL] [Abstract][Full Text] [Related]
2. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
Bakchoul T; Sachs UJ
Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis of chronic immune thrombocytopenic purpura.
McMillan R
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
Gernsheimer T
Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
[TBL] [Abstract][Full Text] [Related]
5. New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia.
Althaus K; Faul C; Bakchoul T
Hamostaseologie; 2021 Aug; 41(4):275-282. PubMed ID: 33348391
[TBL] [Abstract][Full Text] [Related]
6. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of chronic immune thrombocytopenic purpura.
Cines DB; McMillan R
Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
[TBL] [Abstract][Full Text] [Related]
8. Emerging drugs for immune thrombocytopenia (ITP).
Salama A
Expert Opin Emerg Drugs; 2017 Mar; 22(1):27-38. PubMed ID: 28253829
[TBL] [Abstract][Full Text] [Related]
9. The effect of antiplatelet autoantibodies on megakaryocytopoiesis.
McMillan R; Nugent D
Int J Hematol; 2005 Feb; 81(2):94-9. PubMed ID: 15765775
[TBL] [Abstract][Full Text] [Related]
10. Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.
Lev PR; Grodzielski M; Goette NP; Glembotsky AC; Espasandin YR; Pierdominici MS; Contrufo G; Montero VS; Ferrari L; Molinas FC; Heller PG; Marta RF
Br J Haematol; 2014 Jun; 165(6):854-64. PubMed ID: 24673454
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
Nugent D; McMillan R; Nichol JL; Slichter SJ
Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody against integrin α
Zeng DF; Chen F; Wang S; Chen SL; Xu Y; Shen MQ; Du CH; Wang C; Kong PY; Cheng TM; Su YP; Wang JP
J Thromb Haemost; 2018 Sep; 16(9):1843-1856. PubMed ID: 29953749
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
[TBL] [Abstract][Full Text] [Related]
14. Immune thrombocytopenia (ITP): Pathophysiology update and diagnostic dilemmas.
LeVine DN; Brooks MB
Vet Clin Pathol; 2019 Oct; 48 Suppl 1():17-28. PubMed ID: 31538353
[TBL] [Abstract][Full Text] [Related]
15. [The pathogenesis of primary immune thrombocytopenia].
Gudbrandsdottir S; Frederiksen H; Birgens HS; Nielsen CH; Nielsen OJ; Stentoft J; Hasselbalch HC
Ugeskr Laeger; 2011 Jan; 173(4):274-7. PubMed ID: 21262172
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of immune thrombocytopenia.
Audia S; Mahévas M; Samson M; Godeau B; Bonnotte B
Autoimmun Rev; 2017 Jun; 16(6):620-632. PubMed ID: 28428120
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
Stasi R; Evangelista ML; Stipa E; Buccisano F; Venditti A; Amadori S
Thromb Haemost; 2008 Jan; 99(1):4-13. PubMed ID: 18217129
[TBL] [Abstract][Full Text] [Related]
18. The ITP syndrome: pathogenic and clinical diversity.
Cines DB; Bussel JB; Liebman HA; Luning Prak ET
Blood; 2009 Jun; 113(26):6511-21. PubMed ID: 19395674
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.
Ma L; Zhou Z; Zhang D; Yang S; Wang J; Xue F; Yang Y; Yang R
Thromb Haemost; 2012 May; 107(5):937-50. PubMed ID: 22398715
[TBL] [Abstract][Full Text] [Related]
20. [TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA IN ADULTS: UPDATE].
Blickstein D
Harefuah; 2019 Mar; 158(3):196-199. PubMed ID: 30916510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
